Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study

Aim The aim of this randomized placebo-controlled clinical trial was to evaluate the effects of Lactobacillus reuteri-containing probiotic lozenges as an adjunct to scaling and root planing (SRP). Material and Methods Thirty chronic periodontitis patients were recruited and monitored clinically and microbiologically at baseline, 3, 6, 9 and 12 weeks after therapy. All patients received one-stage full-mouth disinfection and randomly assigned over a test (SRP + probiotic, n = 15) or...
Authors: Wim Teughels, Andac Durukan, Onur Ozcelik, Martine Pauwels, Marc Quirynen, Mehmet Cenk Haytac

Evidence-Based Strategies in Weight Loss Mobile Apps

submitted by: spagoto
Background: Physicians have limited time for weight-loss counseling, and there is a lack of resources to which they can refer patients for assistance with weight loss. Weight-loss mobile applications (apps) have the potential to be a helpful tool, but the extent to which they include the behavioral strategies included in evidence-based interventions is unknown. Purpose: The primary aims of the study were to determine the degree to which commercial weightloss mobile apps include the...
Authors: Sherry Pagoto, Kristin Schneider, Mirjana Jojic, Michelle DeBiasse, Devin Mann

Firing up innate immunity to stop asthma attacks

submitted by: mdanderson
The National Institutes of Health will provide $2.4 million to an MD Anderson researcher to advance a completely new approach to stifling asthma attacks. Scott Evans, M.D., of MD Anderson's Department of Pulmonary Medicine, was named an NIH New Innovator for his proposal to jump-start a rapid immune response to stymie viral infections before they can provoke asthma attacks. "Asthma affects 8 percent of Americans -- 26 million adults and children -- and its incidence continues to grow for...